Robot that removes cancer tumours without incisions gets $20.5 mil funding

Professor Lawrence Ho Khek Yu

Robot that removes cancer tumours without incisions gets $20.5 mil funding

By: 
Jude Chan
16/03/17, 04:46 pm

SINGAPORE (March 16): Local medical robotics firm EndoMaster announced Thursday that it raised $20.5 million in March – one of the largest sums for Series B funding for medical technology companies in Singapore.

EndoMaster’s robotic-assisted surgical system is able to remove gastro-intestinal cancer tumours without the need for surgical incisions on the body or organ.

According to EndoMaster, gastro-intestinal cancer is diagnosed in over three million people worldwide and causes more than two million deaths every year.

Current treatments to remove gastro-intestinal tumours require incisions on the abdomen and cutting out the affected sections of the stomach, colon or rectum.

A spin-off by Nanyang Technological University (NTU) and National University of Singapore (NUS), EndoMaster’s non-invasive tumour-removal lowers surgery time to less than one hour.

“The EndoMaster system was designed to enable complicated surgeries to be performed using existing openings like the mouth and anus, without requiring additional surgical access points,” says EndoMaster co-founder Louis Phee.

“In the future, we aim to perform more ‘no-hole’ surgeries on other major organs. The cost and medical benefits are apparent,” Phee adds.

EndoMaster says it is targeting the fast-growing global medical robotics market. The market is growing at a compound annual growth rate of 21.1%, and expected to more than double to US$12.8 billion by 2021.

“The new funds will enable EndoMaster to scale up this disruptive innovation, making endoscopic surgery easy, safe, and accessible to many more doctors in this world,” says EndoMaster co-founder Lawrence Ho.

EndoMaster says it is looking to launch its product in Europe in late 2018. It aims to surpass $100 million in revenue within five years of its product launch.

To find out more about the Master and Slave Transluminal Endoscopic Robot (MASTER), which was featured in The Edge Singapore in March 2014, click to read: Medical marvel.

iXBiopharma's Wafesil granted regulatory approval for treatment of male erectile dysfunction in Australia

SINGAPORE (June 19): iX Biopharma says the Australia’s regulatory authority, Therapeutic Goods Administration (TGA), has given the go-ahead for the use of Wafesil to treat of male erectile dysfunction in the country. Wafesil, formerly known as PheoniX, is a sublingual wafer sildenafil product which comes in a new dose form of sildenafil – the active ingredient in Viagra – in dosage strengths of 25 and 50mg, and pack sizes of four, eight and 12 wafers. It is delivered using iX Biopharma’s proprietary drug delivery technology, WaferiX, and will be supplied to market via wholesaler ....
Read More >>

Trendlines receives FDA regulatory clearance for meniscus repair system

SINGAPORE (June 19): Trendlines Group announced that its portfolio company, Arcuro Medical, has received regulatory clearance from the United States Food and Drug Administration (FDA) for its SuperBall meniscus repair system. This comes after Arcuro completed an extensive and successful series of pre-clinical studies in the US and Israel. Superball is an all-suture meniscus repair system that preserves knee functionality that is secure, reliable, and effective. Currently, practitioners would seek to avoid removal of the meniscus to maintain knee functionality, preferring arthroscopic ....
Read More >>

That democracy can pay off

(June 18): “What have been the really major advances of the past 20 years?” is one of the most common debated questions in my circles. The smartphone is probably nominated most often, while Google, Facebook and fracking have their advocates too. Yet we hardly ever talk about one of the most important developments, perhaps because it raises uncomfortable political issues: the governance technologies and strategies of authoritarian regimes have become much more efficient. I recall the 1970s, when there were many fewer democracies and communism was still a major scourge. Apart from what at....
Read More >>
High-value jobs, skilled talent in high supply at Iskandar Malaysia

SINGAPORE (June 18): Most companies setting up a division overseas struggle to find the right talent